The 6th Vaccine Innovation Forum World (VIF World 2025) is set to take place from March 20-22, 2025, in Shanghai, bringing together global vaccine innovators, scientists, and industry leaders. This premier event will focus on vaccine R&D, manufacturing advancements, regulatory strategies, and commercialization pathways.

Hzymes Biotech, a leading provider of mRNA raw materials and CRO services, is honored to participate in this international event. Visit Booth A15 to explore Hzymes’ comprehensive mRNA solutions and discover cutting-edge technologies that drive mRNA vaccine development forward.

Event Background & Key Highlights

VIF World is a globally recognized platform for fostering innovation in vaccine science, immunology, and biotechnology. This year’s event will feature:

Top industry experts and policymakers discussing the latest vaccine advancements
Breakthrough research on mRNA technology, LNP delivery, and immunotherapy
Networking opportunities between academia, pharmaceutical companies, and regulatory bodies
As the global vaccine market continues to grow, VIF World 2025 plays a crucial role in shaping the future of mRNA drug development and vaccine production.

Hzymes Biotech at VIF World 2025

At Booth A15, Hzymes Biotech will showcase a full suite of mRNA CRO solutions designed to optimize mRNA vaccine production. Attendees can:

Learn about high-quality mRNA raw materials for efficient synthesis and purification
Explore innovative enzymes, nucleotides, and LNP encapsulation solutions
Participate in live product demonstrations and industry discussions
Receive exclusive gifts and interact with Hzymes’ team of experts

Comprehensive mRNA Solutions by Hzymes Biotech

mRNA Platform Overview

Hzymes Biotech offers a complete range of mRNA raw materials and CRO services, including:

High-quality enzymes for mRNA synthesis
Modified nucleotides for enhanced stability
LNP encapsulation for efficient mRNA delivery
mRNA purification and quality control solutions

Key mRNA Raw Materials

(a) Template Production:

BsaI Restriction Endonuclease
BspQI Restriction Endonuclease

(b) In Vitro Transcription:

High-Yield T7 RNA Kit (Standard & Low dSRNA)
T7 RNA Polymerase (DMF36855)
Recombinant RNAase Inhibitor (DMF36854)

(c) mRNA Capping & Tailoring:

Vaccinia Virus Capping Enzyme
Cap 0, Cap 1, Anti-Reverse Cap Analog (ARCA)
Poly(A) Polymerase & Tailoring Reagents

(d) LNP Encapsulation & Purification:

Fast LNP Reagent for Effective mRNA Delivery
mRNA Affinity Chromatography Purification Kit

(e) Quality Control Solutions:

dSRNA Detection Kit
Capping Efficiency & Residue Detection Kits
Comprehensive Testing for mRNA Purity

Hzymes Biotech’s CRO Services for mRNA Development

Hzymes Biotech provides customized CRO services to support mRNA drug development, including:

mRNA Antigen Synthesis for vaccine research
mRNA Process Development for scalable production
LNP Encapsulation & Quality Testing to ensure efficacy
Circular RNA Construction & Purification for next-gen therapies

Why Visit Hzymes Biotech at VIF World 2025?

Gain insights into the latest mRNA vaccine technologies
Network with leading experts in the biotech and pharmaceutical industries
Experience hands-on demonstrations of Hzymes’ advanced mRNA solutions
Get exclusive offers and in-depth consultations from Hzymes’ technical team

Conclusion

Join Hzymes Biotech at Booth A15 at VIF World 2025 in Shanghai to explore the future of mRNA vaccine innovation. Connect with our experts and discover how our cutting-edge solutions can accelerate your mRNA drug development.

Event Date: March 20-22, 2025
Location: Shanghai, China
Contact Hzymes Biotech for more details on mRNA CRO services today!